Assets in USD of Kairos Pharma, LTD. from Q4 2023 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Kairos Pharma, LTD. quarterly Assets history and change rate from Q4 2023 to Q3 2025.
Kairos Pharma, LTD. Assets for the quarter ending 30 Sep 2025 was $8.07M, a 61.2% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Change (%)

Kairos Pharma, LTD. Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$8.07M	+$3.06M	+61.2%	30 Sep 2025	10-Q	14 Nov 2025
Q2 2025	$6.67M			30 Jun 2025	10-Q	12 Aug 2025
Q1 2025	$7.94M			31 Mar 2025	10-Q	14 May 2025
Q4 2024	$5.77M	+$4.8M	+498%	31 Dec 2024	10-Q	14 Nov 2025
Q3 2024	$5M			30 Sep 2024	10-Q	14 Nov 2024
Q4 2023	$965K			31 Dec 2023	10-K	15 Apr 2025

* An asterisk sign (*) next to the value indicates that the value is likely invalid.